AI Outperforms Sonographers in Assessing Heart Function

A study published in the peer-reviewed journal "Nature" found that artificial intelligence (AI) is better at assessing heart function than sonographers.

The study was conducted by investigators at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at Cedars-Sinai and was a first-of-its-kind, blinded, randomized clinical trial of AI in cardiology. Cardiologists more frequently agreed with the initial assessment made by AI and made corrections to only 16.8% of the AI initial assessments. Cardiologists made corrections to 27.2% of the sonographers' initial assessments, and the physicians were unable to distinguish between AI and sonographer assessments. AI also saved cardiologists and sonographers time. The hope is to save clinicians time and minimize the more tedious parts of the cardiac imaging workflow. However, the cardiologist remains the final expert adjudicator of the AI model output. Regulatory approvals are now needed for such tools to be considered for use in clinical practice.

The success of AI in assessing cardiac function presents promising implications for the future of cardiac imaging. The research team is optimistic about the potential for wider adoption of AI in both the clinical and regulatory arenas. Another study conducted by the same investigators revealed that the AI algorithm from CT angiography images accurately predicted heart attack risk within five years, leading the team to believe that AI can help build better prediction models that will quickly get interventions to those who need them, ultimately saving lives.

REFERENCE

He B, Kwan AC, Cho JH, Yuan N, Pollick C, Shiota T, Ebinger J, Bello NA, Wei J, Josan K, Duffy G, Jujjavarapu M, Siegel R, Cheng S, Zou JY, Ouyang D. Blinded, randomized trial of sonographer versus AI cardiac function assessment. Nature. 2023 Apr 5. doi: 10.1038/s41586-023-05947-3. Epub ahead of print. PMID: 37020027.


Comments

Post a Comment

Popular posts from this blog

Emerging Therapies in Heart Failure Management

Image
Heart failure is a significant global health challenge, affecting millions of people worldwide. It arises from various causes, including ischemic heart disease, hypertension, valvular abnormalities, and cardiomyopathies. The primary issue in heart failure is the heart's inability to efficiently pump blood, leading to debilitating symptoms and high mortality rates. Traditional management has focused on alleviating symptoms and enhancing cardiac function through medications and device-based interventions.  Despite the progress in conventional treatments, heart failure continues to be a clinical challenge due to complex underlying mechanisms such as neurohormonal activation, cardiac fibrosis, and cellular remodeling. Several emerging therapies could address these challenges.     Gene therapy , including gene-editing techniques like CRISPR-Cas9, for correcting genetic mutations contributing to heart failure, offers a promising avenue for addressing the root causes of this condition.  
Read more

Assessing Vascular Elasticity through Heart and Pulse Rhythms

Image
A novel inexpensive diagnostic methodology promises to enhance our understanding of vascular elasticity. This innovative approach leverages the patient's heart and pulse rhythms to assess the flexibility of blood vessels.  The elasticity of blood vessels, the ability of their walls to stretch and contract, plays a pivotal role in our cardiovascular health. When blood vessel walls become stiffer, individuals become more sensitive to fluctuations in blood pressure, making them more vulnerable to serious conditions like atherosclerosis and heart disease. The scientists at Samara University have proposed a more straightforward method for evaluating vascular elasticity. This methodology is based on the analysis of differences between the patient's heart and pulse rhythms. According to Dr. Alexander Fedotov, an associate professor at the Department of Laser and Biotechnical Systems at Samara University, "Periodic fluctuations in arterial blood pressure, known as Mayer waves, can
Read more

Wearable Technology for Predicting Postoperative Pulmonary Complications

Image
Postoperative Pulmonary Complications (PPCs) encompass a variety of lung-related issues that can arise after surgeries, especially after major operations like cardiac valve surgery. These complications range from pneumonia and respiratory failure to atelectasis (the partial or complete collapse of the lung), bronchospasm (airway constriction), pleural effusion (fluid accumulation around the lungs), and pulmonary embolism (a lung blood clot). In the rapidly advancing field of healthcare technology, wearable devices are emerging as key tools for predicting and mitigating postoperative complications. Highlighting this trend, a recent exploratory study by Wang et al. explores the potential of wearables in predicting PPCs following cardiac valve surgery. Their study, "A wearable six-minute walk-based system to predict postoperative pulmonary complications after cardiac valve surgery: an exploratory study," examines how wearable technology can be integrated into clinical settings.
Read more